Harvard Bioscience (HBIO) Debt to Equity (2010 - 2026)

Harvard Bioscience (HBIO) reported Debt to Equity of $3.6 for Q1 2026, up 48.71% year-over-year from $2.42 in Q1 2025, and up 38.01% quarter-over-quarter from $2.61 in Q4 2025.

Harvard Bioscience (HBIO) Debt to Equity (2010 - 2026) Analysis & Trends

Harvard Bioscience (HBIO) has 17 years of Debt to Equity data on file, last reported at $3.6 in Q1 2026.

  • Debt to Equity for Q1 2026 came in at $3.6, up 48.71% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.6 (up 48.71% YoY), and the FY2025 annual result was $2.61, up 347.64% from the prior year.
  • Debt to Equity improved to $3.6 in Q1 2026 per HBIO's latest filing, from $2.61 in the prior quarter.
  • Over five years, Debt to Equity peaked at $3.6 in Q1 2026 and troughed at $0.5 in Q4 2023.
  • A 5-year average of $1.19 and a median of $0.63 in 2022 frame the typical range for Debt to Equity.
  • The sharpest annual moves came in 2023 and 2025: Debt to Equity dropped 23.78% in 2023, then jumped 368.38% in 2025.
  • A 5-year view of Debt to Equity shows it stood at $0.65 in 2022, then slipped by 22.83% to $0.5 in 2023, then climbed by 16.61% to $0.58 in 2024, then surged by 347.64% to $2.61 in 2025, then jumped by 38.01% to $3.6 in 2026.
  • Business Quant data shows HBIO's Debt to Equity at $3.6 in Q1 2026, $2.61 in Q4 2025, and $2.41 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Debt/Equity (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn 0.72
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn 1.12
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 0.04
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 0.07
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn 1.02
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn 0.30
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn 1.57
10 Harvard Bioscience 26.17 Mn 19.07 Mn 12.24 Mn 3.60

Historic Data

Download Data
DateValue
Mar 31, 2026 3.60
Dec 31, 2025 2.61
Sep 30, 2025 2.41
Jun 30, 2025 2.22
Mar 31, 2025 2.42
Dec 31, 2024 0.58
Sep 30, 2024 0.58
Jun 30, 2024 0.53
Mar 31, 2024 0.52
Dec 31, 2023 0.50
Sep 30, 2023 0.52
Jun 30, 2023 0.55
Mar 31, 2023 0.59
Dec 31, 2022 0.65
Sep 30, 2022 0.68
Jun 30, 2022 0.63
Mar 31, 2022 0.64
Dec 31, 2021 0.58
Sep 30, 2021 0.59
Jun 30, 2021 0.55